1.Intravenous Thrombolysis Use in Acute Stroke with Cardiac Myxoma
Eun Young KIM ; Han Yeong JEONG ; Yong Seok LEE
Journal of the Korean Neurological Association 2018;36(4):408-410
No abstract available.
Myxoma
;
Stroke
;
Thrombolytic Therapy
2.Thrombolysis in ischaemic stroke in rural North East Thailand by neurologist and non-neurologists
Kannikar Kongbunkiat ; Narongrit Kasemsap ; Somsak Tiamkao ; Verajit Chotmongkol ; Kittisak Sawanyawisuth ; Pawut Mekawichi ; Kasemsin Pavakul ; Pisit Soison ; Janhom Jattawanin ; Panadda Kaitchanon ; Weera Yaowapruek ; Arkom Arayawichanon ; Thanun Thanwiset
Neurology Asia 2016;21(4):325-331
Background & Objective: Acute ischemic stroke (AIS) has been shown to be effectively treated
with thrombolytic therapy. Thailand and other developing countries have limited stroke specialists to
prescribe this treatment. Data regarding stroke outcomes in AIS patients who received thrombolytic
therapy prescribed by neurologists compared with non-neurologists are limited. Methods: This was a
large, multicenter, retrospective study conducted in 9 hospitals across the northeastern part of Thailand.
The inclusion criteria were AIS patients who were admitted and treated with thrombolytic therapy
between January 2010 and December 2012. Patients were categorized into two groups by physician
specialty; neurologist and non-neurologist. Clinical outcomes and in-hospital mortality were compared
between the groups. Results: There were 915 AIS patients who participated in the study; 175 patients
were treated by the non-neurologists (19.1%). The mean age of all patients was 64 years and 55.1%
were men. The median onset to needle time in both groups were similar at 180 minutes. The National
Institutes of Health Stroke Scale (NIHSS) at discharge were significantly higher in neurologist group
than non-neurologist group (NIHSS 6 vs 3, p value 0.03). The in-hospital mortality was also higher
in neurologist group (9.5% vs 4.0%; p value 0.02).
Conclusions: Non-neurologists may be able to thrombolyze AIS patients safely and effectively.
Stroke
;
Thrombolytic Therapy
3.Clinical observation on tongue acupuncture for treatment of stroke.
Qun LI ; Zu-Hong WANG ; Jian YE ; Xiao-Yun ZHU ; Zun-Hui GUAN
Chinese Acupuncture & Moxibustion 2005;25(11):820-822
OBJECTIVETo observe therapeutic effect of tongue acupuncture on stroke.
METHODSOne hundred and ninety cases were randomly divided into an observation group and a control group, 95 cases in each group. The patients in the observation group were treated by tongue acupuncture combined with body acupuncture, and the control group by simple body acupuncture.
RESULTSThe total effective rate was 95.8% in the observation group and 80.0% in the control group, the observation group being significantly better than the control group.
CONCLUSIONTongue acupuncture has a better therapeutic effect on stroke.
Acupuncture Therapy ; Humans ; Stroke ; therapy
4.A clinical trial to treat cerebrovascular accidents - induced aphasia by combining tongue acupuncture with scalp acupuncture
Journal Reasearch of Vietnam Traditional Medicine and Pharmacy 2005;15():25-28
A study was conducted on 45 patients who had aphasia after cerebrovascular accident at Department of Acupuncture in Chinese medicine Institute of Chiangsu, China. Patients were divided randomly into 3 groups: Group 1 was treated by alone scalp acupuncture, group 2 was treated by alone tongue acupuncture, and group 3 was treated by both two methods. Results: Combination of tongue acupuncture and scalp acupuncture is an effective treatment for aphasia after cerebrovascular accident. It has good treatment effectiveness with all kinds of aphasia. The patients in group 3 had better results than the group 1 and group 2
Stroke
;
Therapeutics
;
Aphasia
;
Acupuncture Therapy
5.Not Available.
Chinese Acupuncture & Moxibustion 2023;43(11):1226-1228
Humans
;
Ankle
;
Acupuncture Therapy
;
Stroke
6.Clinical observation on acupuncture for treatment of aphasia due to ischemic stroke at the early stage.
Chinese Acupuncture & Moxibustion 2005;25(11):760-762
OBJECTIVETo observe therapeutic effect of acupuncture on aphasia due to ischemic stroke at the early stage.
METHODSSeventy cases of aphasia due to ischemic stroke at the early stage were randomly divided into an acupuncture group and a control group. The control group were treated with standard medication and rehabilitation direction, and the acupuncture group with the standard medication and rehabilitation direction plus acupuncture. Evaluation and comparison were carried out before treatment and 15 and 30 days after treatment with the western aphasia battery (WAB) AQ indexes.
RESULTSThe WAB AQ index evaluation 15 days and 30 days after treatment in the acupuncture group were better than those in the control group (P < 0.05 or P < 0.001).
CONCLUSIONAcupuncture has synergistic action with the standard medication and rehabilitation direction.
Acupuncture Therapy ; Aphasia ; Humans ; Stroke ; therapy
7.A randomized controlled trial of acupuncture treatment of acute ischemic stroke.
Ping RAO ; Li ZHOU ; Min MAO ; Yang BAI ; Tian-Ming WEN ; Yu-Hong TANG ; Wen-Li GUO
Chinese Acupuncture & Moxibustion 2006;26(10):694-696
OBJECTIVETo explore effects of acupuncture on ability of daily living (ALD) and the incidence rate of disability and mortality of the patient of acute ischemic stroke.
METHODSForty patients with acute ischemic stroke were randomly assigned to an acupuncture group and a control group, 20 cases in each group. The treatment group were treated with acupuncture for 3-4 weeks, 5 times each week, and routine therapy. The control group were treated with routine therapy alone.
RESULTSNo statistically significant differences between the two groups in the score of neurological defection, and the incidence rate of disability and mortality at following survey of 3 and 6 months were found.
CONCLUSIONAcupuncture is safe and feasible for stroke at early stage.
Acupuncture ; Acupuncture Therapy ; Humans ; Stroke ; therapy
8.Observation on therapeutic effect of scalp acupuncture combined with body acupuncture on stroke.
Bo-qing WANG ; Ping ZHOU ; Yu-pu ZHU
Chinese Acupuncture & Moxibustion 2005;25(4):240-242
OBJECTIVETo search for the best acupuncture and moxibustion treatment program for stroke.
METHODSOne hundred and eighty-three cases of stroke were divided into a scalp-body acupuncture group of 62 cases, a scalp acupuncture group of 60 cases and a body acupuncture group of 61 cases. They were treated for 2 months and then their therapeutic effects were compared.
RESULTSIn the scalp-body acupuncture group, 13 cases were basically cured, 32 cases improved obviously, 15 cases improved, 2 cases was ineffective, and corresponding figures in the scalp acupuncture group were 8, 21, 24, 7, and in the body acupuncture group were 11, 28, 19, 3, with a significant difference between the scalp-body acupuncture group and the scalp acupuncture group (P<0.05) , and with no significant differences between the scalp-body acupuncture group and body acupuncture group, and between the body acupuncture group and the scalp acupuncture group.
CONCLUSIONScalp acupuncture combined with body acupuncture has a better clinical therapeutic effect than that of simple scalp acupuncture for the patient of stroke.
Acupuncture Therapy ; Humans ; Moxibustion ; Scalp ; Stroke ; therapy
10.Investigation of the mechanism of action and identification of candidate traditional Chinese medicines for the treatment of ischemic stroke in the Danshen-Jiangxiang pair based on drug-target-disease association network.
Journal of Biomedical Engineering 2023;40(4):762-769
The therapeutic efficacy of Danshen and Jiangxiang in the treatment of ischemic stroke (IS) is relatively significant. Studying the mechanism of action of Danshen and Jiangxiang in the treatment of IS can effectively identify candidate traditional Chinese medicines (TCM) with efficacy. However, it is challenging to analyze the effector substances and explain the mechanism of action of Danshen-Jiangxiang from a systematic perspective using traditional pharmacological approaches. In this study, a systematic study was conducted based on the drug-target-symptom-disease association network using complex network theory. On the basis of the association information about Danshen, Jiangxiang and IS, the protein-protein interaction (PPI) network and the "drug pair-pharmacodynamic ingredient-target-IS" network were constructed. The different topological features of the networks were analyzed to identify the core pharmacodynamic ingredients including formononetin in Jiangxiang, cryptotanshinone and tanshinone IIA in Danshen as well as core target proteins such as prostaglandin G/H synthase 2, retinoic acid receptor RXR-alpha, sodium channel protein type 5 subunit alpha, prostaglandin G/H synthase 1 and beta-2 adrenergic receptor. Further, a method for screening IS candidates based on TCM symptoms was proposed to identify key TCM symptoms and syndromes using the "drug pair-TCM symptom-syndrome-IS" network. The results showed that three TCMs, namely Puhuang, Sanleng and Zelan, might be potential therapeutic candidates for IS, which provided a theoretical reference for the development of drugs for the treatment of IS.
Ischemic Stroke
;
Salvia miltiorrhiza
;
Stroke/drug therapy*
;
Cyclooxygenase 2
;
Prostaglandins